Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Regenerative Medicine
Filter     Order     Display # 
Date Item Title Hits
09 Mar 2010 BioMimetic Therapeutics Presents Promising Pre-Clinical Sports Medicine Data at the 2010 ORS Meeting 79
08 Mar 2010 Acologix Presents Data on Cartilage Regeneration by AC-100 at the 56th Annual Meeting of the Orthopaedic Research Society 4
29 Jan 2010 UT-Battelle Licenses Tissue-regeneration Technologies to NellOne Therapeutics; Advances ORNL Spin-out on Commercialization Path 457
07 Jan 2010 BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB 463
07 Jan 2010 BioMimetic Therapeutics Strengthens its Agreement with Novartis for Exclusive Supply of rhPDGF-BB 37
14 Oct 2009 Study Shows Benefits of Medtronic's INFUSEŽ Bone Graft in Dental Restoration 564
13 Oct 2009 BioMimetic Therapeutics Announces Positive Top-Line Data from its Augment(TM) Bone Graft North American Pivotal Trial 171
14 Sep 2009 Scientific Journal Gene Therapy Reports That Cardium's Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration 638
10 Sep 2009 MESOBLAST'S PROPRIETARY STEM CELLS SUCCESSFULLY REPAIR/REGENERATE DAMAGED INTERVERTEBRAL DISC CARTILAGE 230
17 Aug 2009 Mesoblast Limited (ASX:MSB) Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusion Surgery 499
10 Aug 2009 Compassionate Use Patients in Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants 256
07 Aug 2009 Cytomedix Files Application With FDA for AutoloGel(tm) System in Orthopedics 190
07 Aug 2009 Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 215
26 Jun 2009 TiGenix receives positive CHMP opinion on European MAA for ChondroCelect 509
17 Jun 2009 BioSyntech Reports Positive Results from Pivotal Trial for BST-CarGel(R) Cartilage Repair Device 232
21 Aug 2008 Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion 761
11 Aug 2008 Kuros Biosurgery AG Announces Results Of ONE-Month Follow-Up Of Phase IIa Trial of KUR-212 in Patients with Burns requiring Mesh Grafting; KUR-212 Meets Phase IIa Trial Primary Endpoint 602
28 Jul 2008 Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers 656
18 May 2008 Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement(TM) 702
16 Apr 2008 12 Month Analysis of Juvista Clinical Trials 0050 and 0036 797
28 Mar 2008 OrthoLogic Announces Initiation of Dosing for AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring 724
20 Mar 2008 Mentor Corporation Announces FDA Approval of Prevelle Silk: First Dermal Filler to Prove Pain Reduction in the U.S. 767
16 Mar 2008 BioSyntech Announces Positive Preliminary Interim Data for BST-CarGel(R) Clinical Trial 745
12 Mar 2008 Glycotex Completes Enrollment in Phase IIa Study of Lead Product Candidate GLYC-101 for Wound Healing 741
12 Mar 2008 Nitric BioTherapeutics Launches Phase II Clinical Trial for the Use of Nitric Oxide in the Healing of Chronic Wounds 793
02 Mar 2008 Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery 875
06 Feb 2008 Tornier And BioSET Enter Synthetic Growth Factor Pact 892
24 Jan 2008 Derma Sciences to Enter Phase II Development of Wound Healing Product that May Use Body's Own Naturally Occurring Stem Cells 840
16 Jan 2008 Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor 911
06 Jan 2008 Glycotex, Inc. Obtains Active IND From US Food and Drug Administration for GLYC-101 Wound Healing Compound 891
 
<< Start < Prev 1 2 3 4 5 6 Next > End >>
Results 1 - 30 of 163

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

RNA Therapeutics
Order Now

Subscribe La Merie Biologics